ProCE Banner Activity

Prescription Rates for SGLT2 Inhibitors and GLP-1 Receptor Agonists at Discharge and 1 Yr Later in Persons With T2D and Index MI

Capsule Summary
Conference Coverage

Downloadable slideset reviewing key data on combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists for patients with CVD presented at ADA 2023.

Released: June 28, 2023


Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


This program is supported by an educational grant from Esperion Therapeutics.

Esperion Therapeutics